The γ-globin gene promoter progressively demethylates as the hematopoietic stem progenitor cells differentiate along the erythroid lineage in baboon fetal liver and adult bone marrow

Experimental Hematology

Volumn 35, Issue 1, 2007, Pages 48-55

  Singh, Mahipal ^a,b   Lavelle, Donald ^a,b   Vaitkus, Kestis ^a,b   Mahmud, Nadim ^b   Hankewych, Maria ^a   DeSimone, Joseph ^a,b  

^a JESSE BROWN VA MEDICAL CENTER   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BISULFITE; CD34 ANTIGEN; CD36 ANTIGEN; GAMMA GLOBIN;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; BONE MARROW; CELL DIFFERENTIATION; CELL LINEAGE; CELL MATURATION; CELL SUBPOPULATION; CONTROLLED STUDY; CPG ISLAND; DEMETHYLATION; ERYTHROBLAST; ERYTHROID CELL; ERYTHROPOIESIS; FETUS LIVER; FLUORESCENCE ACTIVATED CELL SORTING; HEMATOPOIETIC STEM CELL; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; TRANSCRIPTION INITIATION;

ANIMALS; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL LINEAGE; CELLS, CULTURED; DNA METHYLATION; ERYTHROBLASTS; ERYTHROID CELLS; ERYTHROPOIESIS; FETUS; GLOBINS; HEMATOPOIETIC STEM CELLS; LIVER; PAPIO; PROMOTER REGIONS (GENETICS);

PAPIO HAMADRYAS;

EID: 33845783811     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2006.09.001     Document Type: Article

References (44)

1. Cedar H. DNA methylation and gene activity. Cell 53 (1988) 3-4
2. Singal R., and Ginder G.D. DNA methylation. Blood 93 (1999) 4059-4070
3. Bender J. DNA methylation and epigenetics. Annu Rev Plant Biol 55 (2004) 41-68
4. Holliday R. DNA methylation and epigenotypes. Biochemistry (Mosc) 70 (2005) 500-504
5. Lyko F., and Brown R. DNA methyltransferase inhibitors and the development of epigenetic cancer therapies. J Natl Cancer Inst 97 (2005) 1498-1506
6. Busslinger M., Hurst J., and Flavell R.A. DNA methylation and the regulation of globin gene expression. Cell 34 (1983) 197-206
7. Lubbert M., Miller C.W., and Koeffler H.P. Changes of DNA methylation and chromatin structure in the human myeloperoxidase gene during myeloid differentiation. Blood 78 (1991) 345-356
8. Cross S.H., and Bird A.P. CpG islands and genes. Curr Opin Genet Dev 5 (1995) 309-314
9. Shiota K. DNA methylation profiles of CpG islands for cellular differentiation and development in mammals. Cytogenet Genome Res 105 (2004) 325-334
10. Robertson K.D. DNA methylation and human disease. Nat Rev Genet 6 (2005) 597-610
11. McGhee J.D., and Ginder G.D. Specific DNA methylation sites in the vicinity of the chicken beta-globin genes. Nature 280 (1979) 419-420
12. Shen C.K., and Maniatis T. Tissue-specific DNA methylation in a cluster of rabbit beta-like globin genes. Proc Natl Acad Sci U S A 77 (1980) 6634-6638
13. van der Ploeg L.H., and Flavell R.A. DNA methylation in the human gamma delta beta-globin locus in erythroid and nonerythroid tissues. Cell 19 (1980) 947-958
14. Mavilio F., Giampaolo A., Care A., et al. Molecular mechanisms of human hemoglobin switching: selective undermethylation and expression of globin genes in embryonic, fetal, and adult erythroblasts. Proc Natl Acad Sci U S A 80 (1983) 6907-6911
15. Siegfried Z., Eden S., Mendelsohn M., Feng X., Tsuberi B.Z., and Cedar H. DNA methylation represses transcription in vivo. Nat Genet 22 (1999) 203-206
16. Singal R., Ferris R., Little J.A., Wang S.Z., and Ginder G.D. Methylation of the minimal promoter of an embryonic globin gene silences transcription in primary erythroid cells. Proc Natl Acad Sci U S A 94 (1997) 13724-13729
17. DeSimone J., Heller P., Hall L., and Zwiers D. 5-Azacytidine stimulates fetal hemoglobin synthesis in anemic baboons. Proc Natl Acad Sci U S A 79 (1982) 4428-4431
18. DeSimone J. The evolving role of DNA demethylating agents in the treatment of sickle cell disease and thalassemia. Semin Hematol 41 (2004) 1-3
19. Nan X., Campoy F.J., and Bird A. MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin. Cell 88 (1997) 471-481
20. Nan X., Cross S., and Bird A. Gene silencing by methyl-CpG-binding proteins. Novartis Found Symp 214 (1998) 6-16 discussion 16-21, 46-50
21. Prokhortchouk E., and Hendrich B. Methyl-CpG binding proteins and cancer: are MeCpGs more important than MBDs?. Oncogene 21 (2002) 5394-5399
22. Hendrich B., and Tweedie S. The methyl-CpG binding domain and the evolving role of DNA methylation in animals. Trends Genet 19 (2003) 269-277
23. Ballestar E., and Esteller M. Methyl-CpG-binding proteins in cancer: blaming the DNA methylation messenger. Biochem Cell Biol 83 (2005) 374-384
24. Rupon J.W., Wang S.Z., Gaensler K., Lloyd J., and Ginder G.D. Methyl binding domain protein 2 mediates {gamma}-globin gene silencing in adult human betaYAC transgenic mice. Proc Natl Acad Sci U S A 103 (2006) 6617-6622
25. Nan X., Ng H.H., Johnson C.A., et al. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature 393 (1998) 386-389
26. Jones P.L., Veenstra G.J., Wade P.A., et al. Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nat Genet 19 (1998) 187-191
27. Siegfried Z., and Cedar H. DNA methylation: a molecular lock. Curr Biol 7 (1997) R305-T307
28. Bird A.P., and Wolffe A.P. Methylation-induced repression-belts, braces, and chromatin. Cell 99 (1999) 451-454
29. Curradi M., Izzo A., Badaracco G., and Landsberger N. Molecular mechanisms of gene silencing mediated by DNA methylation. Mol Cell Biol 22 (2002) 3157-3173
30. Lavelle D., Vaitkus K., Hankewych M., Singh M., and Desimone J. Developmental changes in DNA methylation and covalent histone modifications of chromatin associated with the epsilon-, gamma-, and beta-globin gene promoters in Papio anubis. Blood Cells Mol Dis 36 (2006) 269-278
31. Mahmud N., Patel H., and Hoffman R. Growth factors mobilize CXCR4 low/negative primitive hematopoietic stem/progenitor cells from the bone marrow of nonhuman primates. Biol Blood Marrow Transplant 10 (2004) 681-690
32. Millar D.S., Warnecke P.M., Melki J.R., and Clark S.J. Methylation sequencing from limiting DNA: embryonic, fixed, and microdissected cells. Methods 27 (2002) 108-113
33. Raizis A.M., Schmitt F., and Jost J.P. A bisulfite method of 5-methylcytosine mapping that minimizes template degradation. Anal Biochem 226 (1995) 161-166
34. Lavelle D., Vaitkus K., Hankewych M., Singh M., and Desimone J. Effect of 5-aza-2′-deoxycytidine (Dacogen) on covalent histone modifications of chromatin associated with the varepsilon-, gamma-, and beta-globin promoters in Papio anubis. Exp Hematol 34 (2006) 339-347
35. Amrolia P.J., Cunningham J.M., Ney P., Nienhuis A.W., and Jane S.M. Identification of two novel regulatory elements within the 5′-untranslated region of the human A gamma-globin gene. J Biol Chem 270 (1995) 12892-12898
36. Jane S.M., Amrolia P., and Cunningham J.M. Developmental regulation of the human beta-globin cluster. Aust N Z J Med 25 (1995) 865-869
37. Cross M.A., and Enver T. The lineage commitment of haemopoietic progenitor cells. Curr Opin Genet Dev 7 (1997) 609-613
38. Li L., and Akashi K. Unraveling the molecular components and genetic blueprints of stem cells. Biotechniques 35 (2003) 1233-1239
39. Edelman P., Vinci G., Villeval J.L., et al. A monoclonal antibody against an erythrocyte ontogenic antigen identifies fetal and adult erythroid progenitors. Blood 67 (1986) 56-63
40. Brandeis M., Frank D., Keshet I., et al. Sp1 elements protect a CpG island from de novo methylation. Nature 371 (1994) 435-438
41. Han L., Lin I.G., and Hsieh C.L. Protein binding protects sites on stable episomes and in the chromosome from de novo methylation. Mol Cell Biol 21 (2001) 3416-3424
42. Clark S.J., and Melki J. DNA methylation and gene silencing in cancer: which is the guilty party?. Oncogene 21 (2002) 5380-5387
43. Singh M., Vaitkus K., Hankewych M., Lavelle D., Mahmud N., and DeSimone J. Epigenetic Changes in the {gamma}-Globin gene promoter in hematopoietic progenitor cells at different stages of differentiation. [abstract]. Blood 106 (2005) 1742
44. Lavelle D.E. The molecular mechanism of fetal hemoglobin reactivation. Semin Hematol 41 (2004) 3-10